What issue did the Court consider in Matrixx Initiatives, Inc. v. Siracusano?
a. The Court reviewed the scienter of Siracusano in the case.
b. The Court examined whether Matrixx elected not to disclose the reports of adverse events with the drug Zicam because they understood their likely effect on the market thus meeting the materiality requirement under Section 10(b) of the Securities Act of 1934.
c. The Court determined whether the drug Zicam caused anosmia.
d. The Court studied the FDA approval of Zicam as a drug.
b. The Court examined whether Matrixx elected not to disclose the reports of adverse events with the drug Zicam because they understood their likely effect on the market thus meeting the materiality requirement under Section 10(b) of the Securities Act of 1934
What issue did the Court consider in Matrixx Initiatives, Inc. v. Siracusano? a. The Court reviewed...
EXHIBIT 2 Unofficially Dangerous? Drug Side Effects Title: Author: Adam Liptak Source: New York Times, March 23, 2011, http://www.nytimes.com/2011/03/23 Supreme Court Rules against Zicam Maker health/23bizcourt.html The following is an extract from a New York Times article on Zicam The Supreme Court unanimously ruled on Tuesday that investors suing a drug company for securities fraud may rely on its failure to disclose scattered reports of adverse affects [sic] from an over-the- counter cold remedy that fell short of statistical significance....
Case Study Analysis: Fred Stern & Company, Inc. (Knapp): In the business world of the Roaring Twenties, the schemes and scams of flimflam artists and confidence men were legendary. The absence of a strong regulatory system at the federal level to police the securities markets—the Securities and Exchange Commission was not established until 1934—aided, if not encouraged, financial frauds of all types. In all likelihood, the majority of individuals involved in business during the 1920s were scrupulously honest. Nevertheless, the...
What should have Merck & Co, Inc done differently in regards to river blindness? Merck & Company, Inc.: Having the Vision to Succeed by Stephanie Weiss and David Bollier An Expensive Care for a Poor Market In 1978, Dr. P. Roy Vagelos, then head of the Merck research labs, received a provocative memorandum from a senior researcher in parasitology, Dr. William C. Campbell. Dr. Campbell had made an intriguing observation while working with ivennectin, a new antiparasitic compound under investigation...
How can we assess whether a project is a success or a failure? This case presents two phases of a large business transformation project involving the implementation of an ERP system with the aim of creating an integrated company. The case illustrates some of the challenges associated with integration. It also presents the obstacles facing companies that undertake projects involving large information technology projects. Bombardier and Its Environment Joseph-Armand Bombardier was 15 years old when he built his first snowmobile...